A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2011
11/03/2011	WO2011068953A3 Atoxic recombinant holotoxins of clostridium difficile as immunogens
11/03/2011	WO2011059292A3 Aloe vera sprout concentrate or extract having superior skin cell growth promotion, antioxidant, and anti-allergy effects
11/03/2011	WO2011052919A3 Novel alpha-galactosylceramide derivatives, pharmaceutically acceptable salts thereof, method for preparing same, and pharmaceutical composition for an immune adjuvant, containing the derivatives as active ingredients
11/03/2011	WO2009064155A8 Immunopotentiating composition from labisia pumila extract
11/03/2011	US20110270151 Image-guided energy deposition for targeted drug delivery
11/03/2011	US20110269970 Phenethanolamine Derivatives for Treatment of Respiratory Diseases
11/03/2011	US20110269947 Apo-2 ligand/trail formulations
11/03/2011	US20110269842 Compositions comprising cb receptor agonists, uses thereof and methods for their preparation
11/03/2011	US20110269822 RNAi-Mediated Inhibition of Histamine Receptor H1-Related Conditions
11/03/2011	US20110269811 Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment and prevention of diseases
11/03/2011	US20110269796 Use of Levocabastine for Modulating Generation of Pro-Inflammatory Cytokines
11/03/2011	US20110269781 Compounds
11/03/2011	US20110269772 Axl kinase inhibitors
11/03/2011	US20110269763 CRTH2 receptor ligands for medicinal uses
11/03/2011	US20110269760 Tubulin inhibitors
11/03/2011	US20110269758 Naphthyridinones as protein kinase inhibitors
11/03/2011	US20110269757 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
11/03/2011	US20110269753 Heterocyclic compounds as phosphodiesterase inhibitors
11/03/2011	US20110269749 Tricyclic carbamate jak inhibitors
11/03/2011	US20110269740 Jak kinase modulating compounds and methods of use thereof
11/03/2011	US20110269722 Prodrugs containing novel bio-cleavable linkers
11/03/2011	US20110269713 Bryostatin analogues and methods of making and using thereof
11/03/2011	US20110269709 Prodrugs containing novel bio-cleavable linkers
11/03/2011	US20110269165 Lactic acid bacteria and their cellular components inducing immunoregulatory function, and method of obtaining the same
11/03/2011	US20110268825 Compositions that include anthocyanidins and methods of use
11/03/2011	US20110268805 Adjuvant incorporation in immunonanotherapeutics
11/03/2011	US20110268804 Targeting of antigen presenting cells with immunonanotherapeutics
11/03/2011	US20110268788 Immunotherapeutic agent suitable for the primary prophylaxis of tuberculosis
11/03/2011	US20110268775 Nanoparticle pharmaceutical formulations
11/03/2011	US20110268767 Use of allogeneic cell lines to load antigen-presenting cells to elicit or eliminate immune responses
11/03/2011	US20110268766 Engineered Cells Expressing Multiple Immunomodulators And Uses Thereof
11/03/2011	US20110268765 Injectable Botulinum Toxin Formulations
11/03/2011	US20110268764 Immune response inducing preparations
11/03/2011	US20110268763 Polynucleotides that stimulate neutrophils
11/03/2011	US20110268762 Immunization of avians by mucosal administration of non-replicating vectored vaccines
11/03/2011	US20110268760 Salmonella vectored vaccines against chlamydia and methods of use
11/03/2011	US20110268756 Modified amyloid beta peptide
11/03/2011	US20110268755 Survivin Peptides For Autoimmune Therapies
11/03/2011	US20110268753 Process for regulating immune response
11/03/2011	US20110268752 Inducible Regulatory T-Cell Generation for Hematopoietic Transplants
11/03/2011	US20110268750 Chimeric polynucleotides and polypeptides enabling secretion of a polypeptide of interest in association with exosomes and use thereof for the production of immunogenic compositions
11/03/2011	US20110268737 Hla-g proteins and pharmaceutical uses thereof
11/03/2011	US20110268727 Anti-interferon-alpha antibodies
11/03/2011	US20110268724 Methods and materials relating to cd84-like polypeptides and polynucleotides
11/03/2011	US20110268719 Annatto Extract Compositions, Including Geranyl Geraniols And Methods Of Use
11/03/2011	US20110268716 Methods for the enrichment of viable foxp3+ cells and uses thereof
11/03/2011	US20110268709 Generation of Histocompatible Tissues Using Nuclear Transplantation
11/03/2011	US20110268678 Vitamin d forming sunscreen
11/03/2011	US20110268669 Composition and method for treating eustachian tube dysfunction
11/03/2011	US20110268666 Novel gastroretentive delivery system
11/03/2011	US20110268665 Oil-based foamable carriers and formulations
11/03/2011	US20110268656 J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use
11/03/2011	CA2800891A1 Use of kukoamine a and kukoamine b
11/03/2011	CA2795559A1 Crystalline peptide epoxyketone immunoproteasome inhibitor
11/02/2011	EP2383336A1 Peptide capable of binding to immunoglobulin
11/02/2011	EP2383295A1 IP-10 antibodies and their uses
11/02/2011	EP2383291A2 Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
11/02/2011	EP2383290A2 Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
11/02/2011	EP2382993A1 Combination of drugs with protein-binding prodrugs
11/02/2011	EP2382991A1 Methods for treating conditions associated with MASP-2 dependent complement activation
11/02/2011	EP2382985A1 Recombinant avian-infectious coryza vaccine and method for producing same
11/02/2011	EP2382984A2 GRF analog compositions and their use
11/02/2011	EP2382981A2 Use of Core 2 GlcNac-T inhibitors III for the treatment of inflammatory conditions
11/02/2011	EP2382980A2 Use of Core 2 GlcNac-T inhibitors III for treating vascular complications of diabetes
11/02/2011	EP2382979A2 Use of core 2 GlcNac-T inhibitors III for treating autoimmune diseases
11/02/2011	EP2382978A2 Modulation of the immune system by inositol phospholipids
11/02/2011	EP2382238A1 Anti-lymphotoxin antibodies
11/02/2011	EP2382212A1 Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases
11/02/2011	EP2382211A1 Pyrazole-i, 2, 4 -oxad iazole derivatives as s.phing0sine-1-ph0sphate agonists
11/02/2011	EP2381948A2 Compounds and methods for enhancing erythropoiesis
11/02/2011	EP2381778A1 C5ar antagonists
11/02/2011	EP2222668B1 Tetrahydrocyclopenta[b]indol-3-yl carboxylic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
11/02/2011	EP1836225B1 Kir-binding agents and methods of use thereof
11/02/2011	EP1730194B1 Bi-specific antibodies for targeting cells involved in allergic-type reactions, compositions and uses thereof
11/02/2011	EP1663216B1 Modified release compositions comprising tacrolimus
11/02/2011	EP1425389B1 Human antibodies specific for interleukin 15 (il-15)
11/02/2011	EP1299522B1 Alteration of cell membrane
11/02/2011	CN1753912B Antibodies against PD-1 and uses therefor
11/02/2011	CN102232083A 禽流感疫苗 Bird flu vaccine
11/02/2011	CN102232076A Pyrrolopyrazinyl urea kinase inhibitors
11/02/2011	CN102229877A Brewing method for pine pollen wine
11/02/2011	CN102229667A Polyethylene glycol modified porcine alpha-interferon, preparation method and application thereof
11/02/2011	CN102229562A Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity
11/02/2011	CN102228684A Chinese medicinal composition for enhancing immunity of children and application thereof
11/02/2011	CN102228680A Thymosin phospholipids/bile salt compound micelle and preparation method and preparation thereof
11/02/2011	CN102228619A Chinese patent medicine for treating systemic lupus erythematosus
11/02/2011	CN102228576A Chinese patent medicine for treating discoid lupus erythematosus
11/02/2011	CN102228559A Externally applied ointment for treating children eczema
11/02/2011	CN102228500A Method for producing Euonymus hederaceus Champ. ex Benth preparation and application thereof
11/02/2011	CN102228494A Traditional Chinese medicine composition for supporting healthy energy, strengthening human body immunity, resisting fatigue and tumors, and delaying aging
11/02/2011	CN102228473A Extraction method for active substances in cornua cervi pantotrichum
11/02/2011	CN102228469A Nano-selenium particles and preparation method thereof
11/02/2011	CN102228454A Brain targeting via olfactory pathway fragrant essential oil compound and monomer pharmaceutical composition with functions for preventing and treating brain atrophy and activating brain cells
11/02/2011	CN102228453A Application of 2(ammonia alkyloxy) phenyl pentadiene ketone compound in preparation of drugs for treating chemical ache and/or immunologic injury
11/02/2011	CN101999990B Anti-caries and antiallergic mouth wash
11/02/2011	CN101890045B External medicament for treating infantile eczema
11/02/2011	CN101869695B Medicinal composition for improving immunity and application thereof
11/02/2011	CN101735207B Desloratadine derivative containing gamma-subunit butenolide and synthesizing method thereof
11/02/2011	CN101530462B Composition for treating eczema and preparation method thereof
11/02/2011	CN101014708B Use of antisense oligonucleotides or sirna to suppress expression of eif-5a1

1 ... 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 ... 1172